Grifols is gearing up to file for approval of ... Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health ...

(Reuters) -Spanish renewable energy company Solaria said on Monday it expected energy prices to recover over the year, which would help the firm reach its 2024 profitability target. Solaria shares ...

Results 152 patients (37%) presented bacterial infections at ACLF diagnosis; 46%(n=117) of the remaining 255 patients with ACLF developed bacterial infections during follow-up (4 weeks ... by an ...

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

The global prothrombin complex concentrates market is on a strong upward trajectory, with projections indicating substantial growth in the coming decade. According to a recent report by Future Market ...

After hours: February 3 at 5:37:30 p.m. EST ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, February 03, 2025. Let’s ...

The "Strategic Intelligence: Orphan Designated Drugs" report has been added to ResearchAndMarkets.com's offering.This report consolidates the latest thinking and forecasts around how the healthcare, ...

Grifols S.A. Cl B-0.23% €5.2B Grifols S.A.-1.24% €5.2B ...

20 devilish questions to test your knowledge of the Shipping Forecast. 25 Years of the 21st Century 25 Years of the 21st Century: 1. The Age of Digital Warfare Matthew and his guests look back at ...